Annual Accounts Payable
$5.40 M
-$419.00 K-7.21%
31 December 2023
Summary:
ProShares UltraPro Short Nasdaq Biotechnology annual accounts payable is currently $5.40 million, with the most recent change of -$419.00 thousand (-7.21%) on 31 December 2023. ZBIO annual accounts payable is now -7.21% below its all-time high of $5.82 million, reached on 31 December 2022.ZBIO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$15.08 M
+$6.72 M+80.45%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology quarterly accounts payable is currently $15.08 million, with the most recent change of +$6.72 million (+80.45%) on 30 September 2024. Over the past year, it has increased by +$9.69 million (+179.50%). ZBIO quarterly accounts payable is now at all-time high.ZBIO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBIO Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +179.5% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ZBIO Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -7.2% | at low | at high | +562.6% |
| 5 y | 5 years | -7.2% | at low | at high | +562.6% |
| alltime | all time | -7.2% | at low | at high | +562.6% |
ProShares UltraPro Short Nasdaq Biotechnology Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $15.08 M(+80.4%) |
| June 2024 | - | $8.36 M(-5.3%) |
| Mar 2024 | - | $8.83 M(+63.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $5.40 M(-7.2%) | $5.40 M(+137.1%) |
| Sept 2023 | - | $2.28 M |
| Dec 2022 | $5.82 M | - |
FAQ
- What is ProShares UltraPro Short Nasdaq Biotechnology annual accounts payable?
- What is the all time high annual accounts payable for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly accounts payable?
- What is the all time high quarterly accounts payable for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly accounts payable year-on-year change?
What is ProShares UltraPro Short Nasdaq Biotechnology annual accounts payable?
The current annual accounts payable of ZBIO is $5.40 M
What is the all time high annual accounts payable for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high annual accounts payable is $5.82 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly accounts payable?
The current quarterly accounts payable of ZBIO is $15.08 M
What is the all time high quarterly accounts payable for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high quarterly accounts payable is $15.08 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly accounts payable year-on-year change?
Over the past year, ZBIO quarterly accounts payable has changed by +$9.69 M (+179.50%)